Friday, November 15, 2019
Achieving Competitive Advantage In The Biotechnology Sector Commerce Essay
Achieving Competitive Advantage In The Biotechnology Sector Commerce Essay Biotechnology can be generally defined as the use of living things to create products or to do tasks for human beings. Biotechnology or biotech is used in industry, medicine and agriculture to produce foods, medicine, and test for diseases and remove wastes. (Biotechnologyonline, n.d) As such, there are different types of biotech such as green technology, red technology, and white technology and Bio fuels. In this report, we will have an insight into each of these branches of biotech and use various analytical tools to evaluate how knowledge management is playing a role in creating competitive advantage for companies in the sector. In so doing, we shall look at the Green biotech, Red biotech, White biotech and bio fuel respectively. Green Biotechnology Green technology, otherwise known as plant or agricultural technology is a branch of biotechnology (biotech) which involves the introduction of foreign genes into economically important species, resulting in crop improvement and the production of novel products in plants. (123biotech, n.d.). To better understand the role of knowledge management in harnessing a competitive advantage in this branch of biotechnology, we will take Monsanto as case example. Monsanto is the worlds leading green technology company ahead of rival such as DuPont. (SmartMoney, 2009). The company specialises in breeding (improving the genetic base through technology of crops thus increase yield and genetic engineering (by enhancing generic traits in crops such as insect resistance, herbicide tolerance and drought-tolerance). (SmartMoney, 2009 and Monsanto, n.d.) As with its sister braches such as bioinformatics, white technology(industrial biotechnology), red technology(pharmaceuticals) as well as biofuels, green technology and companies associated with it like Monsanto, are not left unscathed by critics. For instance, Monsanto and its counterpatrs , through its use of plant technology has been criticised of endangering human, the environment and socio-economic.( Friends of the earth, 2006). Significance of Green Technology However, the following advantages are beign celebrated by its supporters: Protection of Crops: for instance, the AT-DBF2 gene from Arabidopsis Thaliana crop injected into plants to enable them withstands Osmotic stress such as drought, salt and stress. (PNAS, n.d.) Increase Crop yield: during the teething years of biotechnology in term of Genetically Modified Food, there has been a widespread criticism of GMO claiming that GM Crops do not increase crop yield, that on the contrary it, reduces it. (Truth about Trade and Technology, 2009). These claims were dismissed by the then USA president Jimmy Carter who stated that, responsible biotechnology is not the enemy; starvation is. (Biotechnology Industry Organisation, n.d.)His favourable stance towards green biotechnology because of organisms like the Bacillus Thuringiensis used to produce the BT-corn. Introduces in 1996, the Bt corn has the potential to simplify management and effectively control corn borers throughout the season thus increasing its yield. (College of Agriculture, n.d.) Improved Food Quality: an example of this was the invention of the Golden Rice by Prof Potrykus and Prof. Beyer of ETH-Zurich and University of Freiburg respectively. The Golden rice is believed to alleviate Vitamin A deficiency in young people especially in the developing world. (Golden Rice, n.d.) Another example is the Maltogenic Amylase used for Retardation of staling in baked food, such as bread and cakes. (Food and Agriculture Organisation, 1997) Having had an insight about how green technology functions, its pros and cons, it is now essential to discover how companies like Monsanto use knowledge management in harnessing and safeguarding innovation in order to create a sustainable competitive advantage against rivals like DuPont. Knowledge Management as a competitive advantage vehicle. To understand the role knowledge management in achieving competitive advantage for biotech companies such as Monsanto, lets apply the Resource-Based View of strategy coined by Grant (1991citied in Henry, 2008). This analysis seeks to analyse how a company exploits its resources to achieve a sustainable competitive advantage against its rivals in the industry. (Henry, 2008) A resource-based view of strategy analysis Consumer Confidence, First Mover Advantage, Tap blue Oceans, CAPABILITY Fund expensive RD, New Product Development RESOURCES Finances, Experts, Human Capital COMPETITIVE ADVANTAGE Knowledge power, Experience curve STRATEGY Differentiation (Grant 1991 cited in Henry 2008) Step 1: Resources: Biotech industries such as Monsanto go beyond the ordinary in Identifying and attaining young talent; because technology can easily be rendered obsolete, there is always the never-ending necessity to pool talent and innovate. Thus, biotech companies like Monsanto are in collaboration with renowned sciences universities like Truman State University to recruit outstanding students with sound sciences background. (Monsanto, n.d.).Furthermore, with their immense finance capability, they are able to fund and exploit these talents. Step 2: Capability: with their finance abilities, these biotech companies are able to fund rigorous Research and Development: Monsanto reported spend $2.6m dollars a day in research and development on how breeding and genetic engineering could develop corn, cotton and soybean seeds that yield more bountiful and nutritious crops and protect against bugs and weeds. (SmartMoney, 2009)This paids off has the company as been able to develop leading brands such as Acceleron, Roundup Ready,Asgrow and Yieldgard for plant resistance to osmotic stress as well as De Ruiter Seeds,Dekalb and Deltapine(Monsanto, n.d.) Step 3: Competitive Advantage: consequently, Monsanto is able to acquire a sustainable competitive advantage due to its ability to create Knowledge power and experience curve on producing competitive and fast selling products like its renowend leading brands like , Acceleron and Roundup Ready Step 4: Strategy: as a result, Monsanto adopt a differentiation strategy. This diferentiation strategy is typical of biotech companies with exception to biofuel companies as they end result; fuel, once drilled and refined is standard worldwide. Step 5: Bridging any resources Gaps: this calls for proactiveness from the part of the company as it involves identifying where the company is weak and formulating adequate strategy to address such weaknesses or resource deficeincies. For instance, tapping blue oceans or untouched markets to increase the companys economies of scale (Henry, 2008) Knowledge Protection in Biotech Use of copyright and licensing: to safeguard knowledge and innovation the company licenses seed germplasm or biotechnology traits to approximately 200 seed partners in the United States. (Monsanto, 2009) In summary, it can be argued that because of the level of technological innovation that occurs in the biotechnology such as green technology, its both a key and critical success factor for company to effectively and efficiently management knowledge by harnessing and protecting its knowledge thus maintain a competitive edge. This we have evaluated using the resourced-based view of strategy analysis coined by Grant (1991 citied in Henry 2008). Red Technology Introduction: The term biopharmaceutical means that developing medicines from using living cells, proteins and nucleic acids. None of the two biopharmaceuticals can be same. Over the past decade world has seen enormous development in this sector. Part 2. The Value Chain Procurement Technology Development Human Resource Management Firm Infrastructure Post Sales Service Inbound Logistics RD Production Marketing Sales MARGIN MARGIN Adopted from Micheal E. Porter Competitive Advantage: Creating and sustaining Superior Performance. (1985 p.37) A lot of researchers like Porter (1985, p36) Henry (2008, p103) have emphasized the importance and application of Value chain analysis. We can assess the strength and weaknesses of any biotechnology company by looking at its resources. It expresses important information about strategy and focus of a particular company. By identifying key focus areas, companies can concentrate in achieving competitive advantages. Biotech companies tend to elongate their value chains by getting into alliance with the business partners; this can either be done by incorporating the concept of upstream or downstream value. Henry (2008, p103) depicts the importance and benefits of adopting this strategy. By exploiting the resources of partners, a biotech company can maximize operational efficiency. This operational efficiency leads to achieve competitive advantage. Each industry sector is unique in terms of function. Biotechnology industry, mostly being a manufacturing industry always works differently as compared to a service industry because of the fact that primary and support activities vary from industry to industry. Porter (1985, 38-40) also supports this fact. Like most of other industries, knowledge management plays a vital role in biotechnology sector and is considered to be a primary activity. Prusak as cited in Young (2008, p5) states that knowledge management is all about the information that is in the brain of individuals as an asset and how it is used to leverage into corporate asset. In biotechnology, explicitly it can be transformed into a corporate knowledge paradigm. This idea is also supported by Gorelick, April and Milton. (2004). In biotechnology sector, even if you look at any sub-sector of biotechnology, industry innovation is the foremost weapon to achieve competitive advantage. Cooke and Mayes (1996, p.13-15) also established relationship of innovation and competition. This mean that by innovation biotech companies achieve competitive advantage and in turns get increased market shares with higher growth rates. The innovation is leading to new effective products thus enabling biotech companies to achieve competitive advantage. By looking at the value chain analysis of biotech industry we come to know that the most valued activity is innovation and knowledge management. That is why biotech companies invest heavily in research and development (RD). For biotech industry RD part of value chain is much more focused and valued. In biofuel, biofood and bioagri the value chain is more or the less same, but when we look at biopharmaceutical and bioinformatics, the value chain tends to alter itself a little bit. The activity that also affects biophrmaceuical is that the phase of clinical trial demands a lot of time, capital and management. Procurement Technology Development Human Resource Management Firm Infrastructure Post Sales Service Inbound Logistics RD Production Marketing Sales MARGIN MARGIN Clinical Trials A typical value chain for biopharmaceutical company. Knowledge is a scarce resource and that is why there are very few biotechnology companies in the market. Adopted from Tzokas, N. and Saren, M. By looking at the above figure it is clear that knowledge management is difficult to achieve. Companies transform their knowledge-based and skills-based information with equipment-based knowledge to create competitive advantage. Theses factors build an organizational culture of innovation and the stake holders like employee and customers force company to come up with new ideas We need to investigate about the potential contribution of each stakeholder-based knowledge pool to the strategic investments, plots and projections undertaken by the biotech firms. The long term development effort needs trust relationship from stockholders that the deliverable of RD can result in to a competitive advantage. This can be done by making multidimensional plans linking knowledge requirements and knowledge pools, thus evolving a knowledge space in which the strategic issues of the firm and its stakeholders can be positioned. As such knowledge space and associated distances can be used as navigational instruments for knowledge utilization. White Technology Biotechnology is now used as a very wide term, but we can say that in general term that it the use of organisms by human . In recent years and past also researchers all over the world got new techniques and ideas to develop biotechnology and changing the future. the most known invention of biotechnology is cloning of animal as well as of name. This amazing technology works at visual as well as molecular level. INDUSTRIAL BIOTECHNOLOGY Industrial biotechnology is recognized everywhere in the world weather to prepare consumer goods, material, chemical.( www.liebertpub.com,12:04) Industrial Biotechnology is the premier forum for this critical field and the only publication bridging biotechnology RD with later-stage commercialization for all industrial and environmental applications . it include fooding items ,textiles, automobiles, pharmaceuticals, cosmetics and body care products and many other products which we use in our daily life. The growing companies in many countries are taking help of biotechnology. By this companies make promise to the public to deliver new and improved products to their customers. Industrial biotechnology is of two types red and white. Red technology is now ignored by the companies and very less companies are dedicated with white biotechnology. PEST ANALYSIS POLITICAL FACTORS The first and the foremost factor to go through in pest analysis is the political factor. Researchers has emphasizes a lot on this factor. One such researcher is Jobber (2007, p79) who is of the opinion that Political and Legal issues can influence marketing decisions by setting the rules by which business can be conducted. Union Laws, Collusion, Abuse of market dominance, acquisitions and mergers, state aid and national laws are few of the political factors that reshape the companies. This factor includes all the political effects which affect the company or an organization. In some business political issues are much higher than any other companies but in case of industrial biotechnology government supports it and make policies to amend it or to improve it so that the future of a country can get improved and standard of living can be increased. All those organizations which do experiments on different methods of industrial biotechnology, government gives rebate from taxes pass legislations and create new departments to look at their working procedures. Strong legislation makes the Through legislation biotech companies are getting their products and processes patented. The biotech companies usually invest heavily in RD and come up with innovative products; these deliverables are end result of knowledge management. By getting the patent biotech companies make sure that their intellectual property right is secured and hence they achieve competitive advantage as no other company can imitate that. In the case of biopharmaceutical, the main governing body is FDA (Foods and Drugs Administration, USA). FDA ECONOMIC FACTOR Economic environment is the second most important factor in PEST analysis. Factors that affect consumer buying power and spending patterns Kotler et al (1999, p158) As evident from the various researchers, monetary policy, interests and exchange rates, income distribution, change in purchasing power, change in spending patterns, availability and rising cost of energy, labor and raw material has lead to significant changing in business world. World economy is in recession, so is the case of UKs. Unemployment ratio has gone up; peoples purchasing power is going down with a less savings. People are naturally focused more on spending towards necessities. Incomes are low. In this case consumer will move toward those products which saves their money and bio-products are one of those products which are cheap and reusable without damaging the envoirment and causing pollution. Envoirment issues are to be considered when it comes to shopping point of view and traveling. Legislation Banerjee, (1998) as cited in Charter and Polonsky (1999, p31), states that The threat of tougher legislation and the rising costs of complying with environmental regulations are possible motivating factors for firms to incorporate environmental concerns in their strategies. Tougher legislation can affect a firm in two ways: first the cost of compliance becomes prohibitive, second, legislation can require substantial changes in product or package design or distribution channels. (Taking back used thing) Public Concern Another important reason for firms to develop an international orientation and strategy is the rise in public concern for the environment. There are literally hundreds of opinion polls on the environment conducted in Europe, Asia and USA. Charter and Polonsky (1999, p32) The need to maintain a good public image and respond to public concerns can lead to firms adopting corporate environmentalism. Charter and Polonsky (1999, p33) Need for competitive advantage There are numerous cases where the installation of new environmentally friendly technologies has reduced costs for firms Charter and Polonsky (1999, p35) Social factors Social / cultural factors include Demographics forces, World Population growth, Age distribution, household structures and social factors. According to Kotler et al (1999, p153) the European and American societies are evidencing huge demographic shifts. Technological Factors Kotler et al. (1999, p165) Forces that create new technologies, creating new product and market opportunities. Those companies which have good knowledge about the new products can develop those and can attract new and existing customers. By this method apart from new technology awareness among public will also able to increase. Companies with better knowledge will develop new products in order to spread awarness among all sectors of consumers. Bibliography? Biofuels Introduction Biotechnology Biotechnology is the use of biological processes, organisms, or systems to manufacture products intended to improve the quality of human life. Biotechnology is an important innovative tool to attain The target the various levels example Bio fuels Bio informative, Bio medics, agriculture Biotechnology proficiency can serve to increase biomass yield, improve crop quality, and convert agriculture waste into bio fuels. (whatistechtarget n.d) Bio fuel It is also knows as agro fuel, these fuels are mainly derived from Biomass or Bio waste. Its often derived from plants and animals. Bio fuel is used faster growing modern technology for transporting sector. Liquid form of fuel is required for most vehicles is this convenient for storage and delivery, hence the bio mass is converted to liquid form. Bio fuel plays a virtual role in modern fuel manufacturing as they are renewable source of energy. Ethanol is the most commonly used Bio fuel in the world particularly in Brazils and largest exporters Asia, Europe and America are the some major producer of bio gases Lleading fuel companies like Bps and Shells company they involved in research and development in bio fuels. (biofuel,n.d) Generic strategies Porters alter the system by reducing its down to three best strategies. Overall Cost leadership Differentiation strategies Focus strategy strategies Overall cost leadership: A firm produced standard product by low cost and also take responsibility of economic scale and experience curve effect. market share is advantage. Differentiation strategies: A company is aimed at broad market. the product must some special feature like advance technology, brand image, etc Focus strategies: In this focus strategies a firm concentrated in market and particular group of consumer. (Reference) Overall cost leadership ? Bio fuel are the cheapest form of fuel you can ever get they dont need big investment in new distribution system but just the basic establishing plant is enough to produce them bio fuel mostly involves in long term investment. Hence Initial investment is very crucial. Its been assessed that share holders all over the world show keen interest in investing huge amount of money in this upcoming promising sector. Differentiation strategies? Bio fuel is renewable source of energy unlike others fuels they have less emission of air pollutants. Hence they are environment friendly; they are very low cost so they can match all the price of leading fuels. The impact of Hybrid cars and green cars with play a massive role in decreasing global warming. Focus strategies? Bio fuel industry will create a big employment opportunities all over the world and helps the countrys economy to develop as well. They provide jobs at all levels even form farmers to scientists. This industry has been welcomed by all countries and they are trying to be innovative to improve this sector all over the world. Most government offer discount and tax reduction on green cars thus encouraging people to buy them. This difference makes the bio fuel market to be more competitive in the fuel market. In forward planning about the global warming all nation now concentrate on bio fuel as they play a vital role in helping to control the pollution. APPLICATION OF PORTERS THEORY TO BIOTECHNOLOGY INDUSTRY Biotech industry has a varied range of applications like in agriculture, molecular biology, health care, pharma sector, chemical industry, environment related and so on. Porters five forces theory helps us to understand and interpret the business processes. This knowledge can be translated to gain a competitive edge over the competitors. This theory is also used to assess the profits that can be generated in the proposed business scenario or the services or products. According to this theory, the five forces that decide the competitive power of the firm in the industry are as follows, Threat of new entrants In the biotech industry, intellectual property is the most important asset. The firms in this industry are heavily dependent on funding to sustain the research and development activities. And very negligible revenue is generated by the firm till the product is developed. So finance is one of the major barrier that keeps away new entrants from the industry. Another barrier that deters the new entrants is the want of specialized knowledge in the area of research or development. Patent rights and proprietary rights also act as barriers to some extent. In some cases where knowledge and patent rights are easily overcome, many small players come into the picture. Although entry is easy for smaller companies, sustenance would be very difficult in this industry. Suppliers As discussed earlier, intellectual property is the most important asset in this industry. The biotech firms usually do not heavily rely on the suppliers. The tools, kits, equipment, chemicals and all other requirements are highly specialized. However small companies who either fail to explore new channels of distribution or who cannot afford the traditional channels of distribution, are at a loss, as they are compelled to enter into marketing alliances. Buyers The power of buyers is not uniform throughout the biotech arena. Earlier, the pharma companies were not affected by the buyers as the customers did not have or had a very little say about the product. The pharma companies had marketing alliances with the hospitals, pharmacists and agents. So the buyer power was less. In case of firms where the major purchasers are the governments or the hospitals, the buyers are strong. But now the health care companies, insurance companies and common man have entered the arena. The increasing price sensitivity of this new group of buyers is forcing the biotech companies to cut the prices and therefore the profit margin is becoming less. In addition to this, governments in some developing countries are pressurizing the biotech companies to take some social responsibility. ( as in the case of providing vaccines for epidemics at an economical price.) So there is a clear shift and the buyers power is increasing. Substitutes The availability of substitutes also depends on the kind of bitech firm/product. If the knowledge and patent rights are not properly protected, the investment in Research and Development (R D) cannot be recovered. If the patent can be easily overcome, some other company can simply copy the formula/application to offer the product at a much cheaper price. So the formulae/knowledge are to be carefully guarded through patenting and Intellectual Property (IP) rights. In some cases, cheaper chemical product alternatives may be available to the sophisticated and more accurate biotech products. Rivalry The competition rivalry is too intense in the biotech industry. Market analysis shows that only 1% of the biotech firms manage to make a profit. Biotech industry is largely dominated by few large firms although there are hundreds of smaller companies. All the firms are struggling to translate their RD efforts into a breakthrough innovation/product. This innovation could potentially change the fate of the firm overnight. So the Intellectual Property is carefully guarded and the rivalry is extremely high in this industry. For example, In U.S, 82 % of biotech firms make 0 % profit, 76 % of firms have less than 50 employees and only 30 companies have more than 300 employees. Porters five forces theory certainly helps in understanding the pros and cons, the opportunities and threats in the business situation. This theory definitely aids in evolving a business strategy. but this theory may not be of great help in assessing the degree of ease or difficulty or profitability in dealing with the business situation. In this context, this theory does not consider the following strategic influences like, Industry merges and acquisitions have become the norm of the day and the consequences of such deals cannot be assessed and is not taken into consideration. Research and innovation has the potential to dramatically change the face of the industry. As new discoveries/innovations occur, many new threats/opportunities spring up. This makes the biotech industry a highly vulnerable one. This aspect is left out by the theory.
Wednesday, November 13, 2019
Artificial Intelligence and Angelology :: Technology Science Computers Essays
Artificial Intelligence and Angelology ABSTRACT: Recently, as I have become more computer-literate, I have noticed some interesting parallels between computer mechanisms and Aquinasââ¬â¢ metaphysics of angelic faculties. The present essay expands on some of the analogies which Aquinas himself, though no proponent of AI theory, might have found interesting. One of the philosophy newsgroups on the Internet is entitled "comp.ai.philosophy." This group features constant variations on questions such as: how close can artificial intelligence (particularly computers) approximate to human consciousness? is free will reducible to neurological mechanisms? and so forth. From my unscientific sampling, I would estimate that the clientele of this newsgroup is about evenly split between those who tend towards a reductive materialism, and those who maintain that consciousness or some element in human consciousness is not reducible to neural structures or functions. So the classical "Hobbes vs. Berkeley" debate continues on into the twenty-first millennium. One of the problems facing those who theorize about the independence and irreducibility of consciousness is the fact that it is difficult to conceptualize the essence of consciousness, as distinct from the sensations, feelings, etc. that are often associated with consciousness. Here we are definitely getting into abstract metaphysics. Medieval philosophers such as Aquinas, Duns Scotus and Suarez faced up to this challenge with a little help from Christian revelation, by speculating about the characteristics and functions of angels or "separate substances," who would presumably exemplify consciousness in its "pure" state, without any distracting admixtures. In this paper, I would like to take a look in particular at Aquinas' theory of separate substances. With this theory, we bypass the old question of the reducibility or irreducibility of consciousness to its material conditions, and we also find, in my opinion, some interesting analogies to contemporary computer technology. It would be too much to hope that these analogies, even if substantial, would instigate a revival of interest in Angelology among technophiles. But those interested in the metaphysics of the mind-body problem may find them suggestive: Microprocessors and Angelic Self-possession: The microprocessors of today's computers are integrated circuits which contain the CPU on a single chip. The latest developments, with variable clock speeds now often exceeding 200 MHz, include Intell's Pentium chip, the IBM/Apple/Motorola PowerPC chip, as well as chips from Cyrix and AMD. The CPU chip is the heart of the computer; only memory and input-output devices have to be added. A small fan might be added on top of the fastest chips to cool them down, but in the chip itself there are no moving parts, no complex gaps between the movement being imparted and that which imparts the movement.
Monday, November 11, 2019
France’s chemical giant
DrumheadIn 1995 Fisons plc was acquired by Pennsylvania-based Rhone-Poulenc Rorer, Inc. , in bend entirely owned by France ââ¬Ës chemical giant Rhone-Poulenc S.A. Though its position among the universe ââ¬Ës pharmaceutical companies was later subsumed in beds of corporate ownership, Fisons had boasted a history of more than 300 old ages in concern before its dismantlement. Founded as a flour factory in the late eighteenth century, it rapidly developed into one of the universe ââ¬Ës largest fertiliser manufacturers. As the fertiliser market matured into a low-profit trade good over the class of the twentieth century, the company diversified into horticultural merchandises, pharmaceuticals, and scientific instruments. In the mid-1980s, Fisons divested its fertiliser involvements to concentrate on the extremely profitable medical side of the concern. By 1993 the company was the universe ââ¬Ës third-largest maker of scientific instruments and ranked among the universe ââ¬Ë s 60 largest pharmaceutical concerns. Fisons ââ¬Ë weak research and development attempts and unequal selling attempts, nevertheless, led to one-year losingss and a steep diminution in its stock monetary value mid-decade. The British company tried to contend off the progresss of its Franco-American rival, but relinquished ownership in the autumn of 1995. Fisons plc began as a flour factory and bakeshop founded by James Fisons in Barningham, England, in the late eighteenth century. In 1789 a boy, besides named James, started a maltings concern that expanded into Stowmarket and Thetford, two river towns that helped the household concerns expand. James Fison and Sons was formed in 1808, and by 1840 the house was entering & A ; lb ; 100,000 in one-year gross revenues. Subsequently that decennary, the household entered the underdeveloped field of fertilisers and moved the concern ââ¬Ës central office to Ipswich. Within a few old ages, Fisons had built a manure plant and was bring forthing its ain sulphuric acid. As fertilisers became the company ââ¬Ës primary concern, pesticides based on sulfurs were added to the merchandise mix. In 1895 the company was split into two parts: James Fison and Sons and Joseph Fison and Co. During World War I, Fisons helped do explosives, but the company returned to fertilizer by the terminal of the war to buoy dwindling nutrient production. When fertiliser monetary values plunged after the war, the two Fison companies, along with two others with which they had late merged, were reunited to organize Fison, Packard, Prentice and Co. ( Fisons ) in 1929. During the 1930s, Fisons began to spread out through acquisitions. The company ââ¬Ës most important add-on was the Anglo-Continental Guano Works Ltd. , which doubled the size of Fisons. Anglo-Continental was a budding pudding stone with a pharmaceutical subordinate, Genatosan ; Fisons was therefore brought into that moneymaking market. Fisons ââ¬Ë acquisitions continued throughout the 1930s, and by 1939, with 39 subordinates, it was the largest fertiliser company in Great Britain. During World War II Fisons felt the force per unit area of both a manpower deficit and increased demand for fertilisers. Some of the company ââ¬Ës fabrication workss were bombed every bit good. The company name was shortened to Fisons Ltd. for marketing lucidity in 1942, and it emerged from the war with about two-thirds of Great Britain ââ¬Ës fertiliser market. Fisons made more acquisitions after the war ââ¬Ës terminal, first buying Wiffen and Son, a all right chemicals maker. The new subordinate became portion of Fisons ââ¬Ës chemicals and biologicals division, headed by Genatosan. The Wiffen acquisition included the Loughborough Glass Company, which would subsequently develop into Fisons ââ¬Ës Scientific Equipment division. The purchase of Pest Control Limited during the 1950s brought Fisons into agrochemicals, a market that was closely related to the fertiliser concern. Fisons hoped to capitalise on the two Fieldss ââ¬Ë common research, development, and distribution methods. In 1968 research workers at Genatosan discovered disodium cromoglycate ( DSCG ) , which was developed as the branded anti-allergenic Intal. The drug differed from its rivals because it was a contraceptive, whereas others were taken after the oncoming of allergic symptoms. Intal gross revenues boosted the pharmaceutical division ââ¬Ës net incomes from & A ; lb ; 1.14 million in 1968 to & A ; lb ; 2.43 million in 1970 and & A ; lb ; 5.6 million in 1973. By 1971 Fisons had organized its many subordinates into four divisions: Fertilizers, Agrochemicals, Pharmaceuticals, and Scientific Equipment. The company developed these primary concerns through acquisitions every bit good as merchandise and market enlargement. Acquisitions were focused geographically in Europe, Australia, and the United States. Fertilizers contributed 50 per centum of the pudding stone ââ¬Ës one-year gross revenues at that clip, and Fisons fought to keep a competitory border in Great Britain ââ¬Ës fertiliser market: 80 per centum of the division ââ¬Ës gross revenues were in its place state. However, the supply side of this division was hamstrung, since its primary ammonium hydroxide provider was besides its primary rival, Imperial Chemical Industries plc. During the first half of the 1970s, Fisons tried to rectify this state of affairs by increasing its majority purchasing in planetary markets, particularly sponsoring Morocco. Morocco increased its monetary values six-fold in 1973, though, and other providers rapidly followed suit. At the same clip, U.K. monetary value controls held fertiliser monetary values below the universe market monetary value for ammonium hydroxide, efficaciously extinguishing Fisons ââ¬Ës fertiliser net incomes. Fisons ââ¬Ës Agrochemicals group besides ran into problem during the seventiess, when it lost a valuable client, Ciba-Geigy Ltd. Fisons tried to back up this group by increasing capital investings, particularly in the United States. The company besides boosted research and development financess, but since most of this division ââ¬Ës attempts focused on making replacements for merchandises that were already on the market, Fisons lacked a strong merchandising suit. During the 1970s, anti-allergens comprised between 60 and 70 per centum of the Pharmaceutical division ââ¬Ës gross revenues, but Intal had merely captured 6.1 per centum of the anti-allergy market, which was led by Glaxo ââ¬Ës Ventolin. After a decennary of research, the division was covering a serious blow when Fisons decided non to market its new drug, Proxicromil, a replacement to Intal, because it was found to do malignant neoplastic disease in animate beings. With Intal ââ¬Ës unrenewable patents set to run out in 1982, the Pharmaceutical division ââ¬Ës chances were non good. In 1972 the Scientific Equipment Division was spun off from the Pharmaceutical division, and acquisitions in Germany and Australia, every bit good as the purchase of Britain ââ¬Ës Gallenkamp, helped Fisons go Great Britain ââ¬Ës top scientific equipment maker. Many of Gallenkamp ââ¬Ës contracts were with the authorities, universities, and infirmaries, nevertheless, many of which cut their outgos in the recessive 1970s. Fisons ââ¬Ës Horticulture division was separated from the Agrochemical division in 1977. It produced and marketed amateur and professional horticulture merchandises, and its strengths were in peat-based merchandises, particularly the popular and well-established Fisons Gro-Bags ââ¬â self-contained, nutritionally balanced dirt pokes. The peat operations were extended with a new works in Yorkshire and the acquisition of Howlett ââ¬Ës, a company with peat militias in Cumbria and Scotland. Although it was a new focal point for Fisons, gardening was really one of the company ââ¬Ës most unafraid concerns by the terminal of the seventiess. It was vertically incorporate and held commanding portions of the markets in which it operated: 50 per centum of the lawn fertiliser market ; 20 per centum of the solid fertiliser market ; 30 per centum of the peat market ; and 12 per centum of Great Britain ââ¬Ës weed and pest control concern. Throughout the 1970s, Fisons had gone into debt to do a cloudy reorganisation and shore up up its historical focal point ââ¬â fertilisers ââ¬â merely as competition and planetary consolidation in this market eroded net incomes. At the same clip, high involvement rates and rising prices dug into the net incomes Fisons managed to gain through its other operations. By 1980 Fisons ââ¬Ës chances looked dim. The Fertilizers division was runing at a loss ; Agrochemicals could non trust to vie with the research and development spendings of bigger rivals ; the Scientific Equipment division was enduring from authorities cutbacks ; gardening was a little, developing concern ; and the Pharmaceuticals division, a primary profit-maker, had all of a sudden lost its lone long-run growing merchandise. Fisons was on the brink of bankruptcy. John Kerridge was promoted to main executive officer ( CEO ) from executive manager in mid-1980 and given the undertaking of change by reversaling Fisons ââ¬Ë downward spiral. He began the reformation by cutting costs, shuting down four production units and three farms in the Fertilizer division, so extinguishing more than 1,000 places in the group. Fisons ââ¬Ës corporate central offices were moved from high-rent London back to Ipswich, and economizations were made in the Scientific Equipment division every bit good. Kerridge ââ¬Ës most cardinal alteration was the sale of the Fertilizer division to Norsk Hydro a.s. in 1982 for & A ; lb ; 59 million. The divestment was a extremist alteration for Fisons and involved the disposal of what had been the foundation of the company for more than a century, every bit good as the division with the most gross revenues. The troublesome Agrochemicals division was sold the undermentioned twelvemonth to Schering A.G. for & A ; lb ; 60 milli on. These divestments left Fisons with three primary concerns: Pharmaceuticals, Horticulture, and Scientific Equipment. The pharmaceutical group was expanded with the 1980 purchase of Great Britain ââ¬Ës Charnwood Pharmaceuticals, Australia ââ¬Ës Orbit Chemical Pty. Ltd. in 1982, and Italy ââ¬Ës Intersint in 1983. Great Britain ââ¬Ës Weddel Pharmaceutical was acquired in 1983 and merged with Charnwood, which would specialise in generic drugs. Fisons ââ¬Ës Horticultural operations grew geographically through a joint venture with Canada ââ¬Ës Western Peat Moss in 1980, and the acquisition of Langley Peat North Ltd. of Alberta in 1983. These purchases gave Fisons entree to big peat supplies and the North American market. The British operations were supplanted with the acquisition of Webb and Bees seed operations from Shell Holdings ( U.K. ) Ltd. in the early 1980s. The Scientific Equipment division grew through the add-on of Watson Victor, a New Zealand distributer of research lab equipment, in 1982. Haake-Butler Instruments, of which Fisons owned 67 per centum, was later founded in the United States. Overall, Kerridge ââ¬Ës cardinal alterations improved Fisons ââ¬Ës balance sheet dramatically ; the corporation went from doing one-year involvement payments of & A ; lb ; 13 million in 1980 to holding no net adoptions in 1983. Fisons was even unafraid plenty to do a successful stock offer of & A ; lb ; 28 million that twelvemonth. The Pharmaceutical division ââ¬Ës continued heavy research and development outgos resulted in two new drugs: DSCG-based Opticrom, released in 1984, and Tilade, a new asthma intervention, introduced in 1986. This division acquired Laboratorios Caesen, of Spain, in 1984, and Bracco de Mexico in 1986. Kerridge was made president in 1984, and he clarified the scheme he had been utilizing to turn Fisons around: ââ¬Å" We wish to run in industries of built-in attraction, which have potency for growing and a record of profitableness of successful participants, [ and ] we wish to be in clearly defined concern sections where Fisons can moderately draw a bead on to being an effectual rival by virtuousness of its size and its fiscal and managerial resources. â⬠The company would no longer run on the peripheries of its chosen markets, as it had in the seventiess. For illustration, Fisons concentrated on the gardening and scientific equipment markets, which were non yet consolidated or dominated by a individual powerful company. Fisons hoped to be that company. Fisons burst onto the U.S. market for scientific equipment, which was place to 40 per centum of the universe ââ¬Ës research activity, with the acquisition of Curtin Matheson Scientific Inc. ( CMS ) in 1984. CMS was the second-largest distributer of scientific equipment in the United States. Fisons besides purchased United Diagnostics Inc. and Pacific Hemostasis Laboratories Inc. , which were combined with CMS to give the latter fabrication capacity. By the beginning of 1985, Fisons ââ¬Ë Scientific division was the third-largest organisation of its type in the universe and the largest outside the United States. Fisons continued to turn, geting in 1985 Murphy Chemical, which helped widen the Horticulture division ââ¬Ës portfolio of merchandises, extend selling in Europe and North America, and shore up Fisons ââ¬Ës peat supplies. Subsequently in the decennary, the Horticulture division would sell its 50 per centum portion of Asef-Fison B.V. to its joint-venture spouse, DSM Agro Specialties B.V. In 1986 Fisons bought Applied Research Laboratories, a taking maker of scientific equipment with planetary selling capacity, and two old ages later it purchased Union Scientific Limited, a Hong Kong company. Several of import acquisitions were besides made by the Pharmaceutical division in the late eightiess. Italchimici SpA, an Italian house, and Pennwalt Corporation ââ¬Ës pharmaceutical division, a U.S. maker of ethical and nonprescription drugs, were purchased in 1988. A Gallic company, Gerbitol S.A. , brought expertness in cardiovascular medical specialty, antibiotics, and dietetic addendums to the division in 1989. In all, with the aid of its important 1980s acquisitions, Fisons ââ¬Ës pre-tax net incomes increased by an norm of 56 per centum per twelvemonth to & A ; lb ; 230 million ( US $ 410 million ) . The corporation ââ¬Ës market capitalisation rose from & A ; lb ; 40 million in 1980 to & A ; lb ; 3 billion in 1990. The 1990 purchase of VG Instruments, a maker of mass spectrometers and surface analysis instruments, more than doubled Fisons ââ¬Ë end product of analytical instruments and catapulted the Scientific Equipment division to the figure three topographic point in the planetary market place. It looked as if Fisons had launched its 2nd back-to-back decennary of growing and prosperity. By the terminal of 1991, nevertheless, it was clear that jobs in the Pharmaceutical division had dragged the full company down. Late that twelvemonth, Fisons revealed that two of its of import new drugs, Opticrom for hay febrility and Imferon for anaemia, had been recalled from the U.S. market after the Food and Drug Administration ( FDA ) denied blessing of the company ââ¬Ës British mills. Harmonizing to a 1992 Economist article, the FDA ââ¬Ës everyday cheque of Fisons ââ¬Ë U.K. mill revealed warehouses with holes in their outside walls ; hapless record maintaining ; and ââ¬Å" the possibility of gnawer, insect or avian activity in the [ conveyance ] containers. â⬠Fisons ââ¬Ës pre-tax net incomes for 1991 dropped 17 per centum to & A ; lb ; 190 million, and the company faced needed investings of more than & A ; lb ; 25 million to convey its British mill up to U.S. criterions. John Kerridge resigned ââ¬Å" on wellness evidences â⬠in mid-January 1992 and was temporarily replaced by Patrick Egan. In April of that twelvemonth, Egan became president, while Cedric Scroggs was selected as main executive officer. The new leaders decided to sharpen Fisons ââ¬Ë focal point on pharmaceuticals and scientific equipment by depriving its OTC drug and horticultural concerns. In November 1992, Fisons agreed to sell its North American OTC drug operations to Swiss drug concern Ciba-Geigy Ltd. for & A ; lb ; 92 million ( US $ 60.3 million ) . This section represented about 50 per centum of Fisons ââ¬Ës planetary consumer wellness division gross revenues and 40 per centum of that group ââ¬Ës net incomes. Egan and Scroggs recognized that the British company lacked the resources and marketing influence necessary to vie in the American consumer drug market. Fisons ââ¬Ës new direction forged a joint development and selling understanding with Allergan Inc. , a U.S. ocular company, early in 1993. The agreement called for Fisons ââ¬Ë 400 U.S. sales representative to co-market Allergan ââ¬Ës ocular drug Acular. The U.S. company ââ¬Ës gross revenues force, in bend, would assist market Fisons ââ¬Ë ocular intervention Opticrom. The agreement presumed that Opticrom would be re-registered by the FDA. By early 1993, Fisons had made important betterments in its Opticrom mill, but new FDA reviews had still non resulted in blessing tardily in the twelvemonth. Fisons suffered yet another reverse when it suspended development of an asthma medical specialty, tipredane. The company had been banking on the new drug to bolster its core respiratory concern in the late ninetiess. Tipredane had been licensed by Fisons from Bristol-Myers Squibb Co. and was in the thick of unsuccessful clinical tests in more than a twelve states. The failure of tipredane left Fisons with merely one new drug, remacemide ââ¬â an epilepsy intervention ââ¬â in development. In May 1993 Fisons sold its North American gardening concern to a pool led by Macluan Capital Corp. of Vancouver for US $ 60 million in hard currency and used the returns to cut down its debt. Fisons besides planned to sell the balance of its Horticulture division every bit shortly as an chance arose. In July the company sold its consumer wellness merchandises concern in Australia and New Zealand to Warner-Lambert for about US $ 23 million. The sale included the Rosken line of curative skin-care merchandises. Despite Fisons ââ¬Ës early 1990s attempts to bolster its pharmaceutical concern, some analysts insisted that the company had neither the research and development strength nor the selling clout necessary to vie in an ethical pharmaceutical concern that demanded frequent find of advanced medical specialties. Industry perceivers anticipated an at hand amalgamation or coup d'etat for Fisons. Those outlooks intensified as Fisons ââ¬Ë portion monetary value declined from & A ; lb ; 2.45 in mid-1992 to & A ; lb ; 1.13 by the terminal of 1993. Over the class of the latter twelvemonth, the company ââ¬Ës scientific instruments division went & A ; lb ; 16 million into the ruddy. CEO Cedric Scroggs was fired that December, Finance Director Roy Thomas took early ( and presumptively nonvoluntary ) retirement, and Stuart Wallis took the helm of the beat-up house. Throughout the 18 months, Wallis made a valorous and moderately successful attempt to bolster Fisons ââ¬Ë stock monetary value. Though the company suffered a loss on 1994, a major reorganisation and divestment plan eliminated at least 1,000 occupations, cut costs, and helped the house ââ¬Ës stock monetary value rebound about 75 per centum to & A ; lb ; 1.93 by mid-August 1995. That addition was non plenty to forestall Franco-American rival Rhone-Poulenc Rorer, Inc. ( R-PR ) from doing a hostile & A ; lb ; 1.7 billion ( US $ 2.6 billion ) command for control of Fisons on August 18th. Though some analysts thought the offering monetary value, at 16.7 times expected net grosss, was excessively high, CEO Wallis complained to Chemical Marketing Reporter that the monetary value ââ¬Å" significantly undervalues Fisons. â⬠The British company backed up that averment when it reported a 40 per centum addition in net income, to & A ; lb ; 48.6 million, for the first half of 1995. That happy intelligence helped progress the house ââ¬Ës stock to & A ; lb ; 2.60 by the terminal of September. In October, R-PR upped its command of & A ; lb ; 2.65 per portion, or US $ 2.9 billion. Unable to happen a more amicable suer, Fisons accepted the coup d'etat that month. Though the British house and its many subordinates around the universe continued to be listed among R-PR ââ¬Ës operations through 1996, it shortly became clear that the tri-centenarian entity would finally discontinue to be. Over the class of 1996 and 1997, R-PR slashed about 3,000 excess occupations in the United States and Great Britain, divested several Fisons divisions ( including the scientific instruments concern ) , and discontinued many of the subsumed company ââ¬Ës pharmaceutical research and development plans. For its about US $ 3 billion, Rhone-Poulenc Rorer got an main course into the US $ 15 billion and turning respiratory drug market, or more specifically, the respiratory drug bringing section. At the clip of its purchase, Fisons had two promising bringing media in the development grapevine: a non-CFC aerosol and a dry-powder inhalator. Indeed, Fisons probably played a function in an addition in gross revenues and cyberspace at R-PR from 1995 to 1996. Year-over-year grosss increased six per centum, to US $ 5.4 billion, and net grew by about one-third, to US $ 473.5 million. In November 1997, when Rhone-Poulenc acquired the staying tierce of R-PR that it did non already ain, Fisons ââ¬Ë destiny appeared sealed. Officials at the company ââ¬Ës U.S. and U.K. central offices early in 1998 asserted that Fisons no longer existed, either as a group of subordinates or a division. Question-1Discuss the grounds from the instance and the usage of theory, the stakeholder direction by this organisation ; chiefly its booby traps? Answer: Question-2How would you hold handled this state of affairs ; suggestions to be rationalized with strong theoretical underpinning? Answer: Question-3At the clip of John Kerridge ââ¬Ës surrender, what strategic options did Patrick Egan have to steer the company back to its old glorification? Answer:
Friday, November 8, 2019
Daniel Hale Williams, Heart Surgery Pioneer
Daniel Hale Williams, Heart Surgery Pioneer American physician Daniel Hale Williams (January 18, 1856- August 4, 1931), a pioneer in the field of medicine, was the first African American to perform successful open heart surgery. Dr. Williams also founded Chicagos Provident Hospital and co-founded the National Medical Association. Fast Facts: Dr. Daniel Hale Williams Full Name: Daniel Hale Williams, IIIBorn: January 18, 1856 in Hollidaysburg, PennsylvaniaDied: August 4, 1931 in Idlewild, MichiganParents: Daniel Hale Williams, II and Sarah Price WilliamsSpouse: Alice Johnson (m. 1898-1924)Education: M.D. from Chicago Medical College (now Northwestern University Medical School)Key Accomplishments: First African American to perform successful open heart surgery, founder of Provident Hospital (the firstà black owned and operated interracial hospital in the U.S.), and co-founder of the National Medical Association. Early Years Daniel Hale Williams, III, was born on January 18, 1856 to Daniel Hale and Sarah Price Williams in Hollidaysburg, Pennsylvania. His father was a barber and the family, including Daniel and his six siblings, moved to Annapolis, Maryland, when Daniel was a young boy. Shortly after the move, his father died from tuberculosis and his mother moved the family to Baltimore, Maryland. Daniel became a shoemakers apprentice for a while and later moved to Wisconsin, where he became a barber. After graduating from high school, Daniel grew interested in medicine and served as an apprentice to a well known local surgeon, Dr. Henry Palmer. This apprenticeship lasted two years, and then Daniel was accepted to the Chicago Medical College, affiliated with Northwestern University. He graduated in 1883 with an M.D. degree. Career and Accomplishments Dr. Daniel Hale Williams began practicing medicine and surgery at Chicagos South Side Dispensary. He was also the first African American anatomy instructor at Chicago Medical College, where he taught notable future physicians such as Mayo Clinics co-founder Charles Mayo. By 1889, other notable appointments for Dr. Williams included the City Railway Company, the Protestant Orphan Asylum, and the Illinois State Board of Health. These were very unique accomplishments for the time, considering that there were very few black doctors at this point in African American history. Dr. Williams gained a reputation as a highly skilled surgeon whose practice included treatment for all patients, regardless of race. This was life-saving for African Americans at the time because they were not allowed admittance to hospitals. African American doctors were not allowed on staff in hospitals either. In 1890, a friend of Dr. Williams asked him for help as his sister was being denied entrance into nursing school because she was black. In 1891, Dr. Williams founded the Provident Hospital and Nursing Training School. This was the firstà black owned and operated interracial hospital in the U.S. and served as a training ground for nurses and African American doctors. First Open Heart Surgery In 1893, Dr. Williams gained notoriety for successfully treating a man, James Cornish, with stab wounds to the heart. Although physicians at the time were aware of the revolutionary works of Louis Pastuer and Joseph Lister in relation to germs and medical surgery, open heart surgery was generally avoided due to the high risk of infection and subsequent death. Williams had no access to X-rays, antibiotics, anesthetics, blood transfusions, or modern equipment. Employing Listers antiseptic technique, he performed the surgery suturing the pericardium (protective lining) of the heart. This would be the first successful heart surgery performed by an African American and second by an American doctor. In 1891, Henry C. Dalton had surgically repaired a pericardial wound of the heart on a patient in St. Louis. Later Years In 1894, Dr. Williams obtained the position of surgeon-in-chief at Freedmens Hospital in Washington, D.C. This hospital served the needs of the poor and newly freed slaves after the Civil War. In four years, Williams transformed the hospital, making dramatic improvements in the admission of surgical cases and drastically reducing the hospitals mortality rate. Dr. Daniel Hale Williams succeeded in the face of discrimination his entire life. In 1895, he co-founded the National Medical Association in response to the American Medical Associations denial of membership to blacks. The National Medical Association became the only national professional organization available for black physicians. In 1898, Williams resigned from Freedmens Hospital and married Alice Johnson, daughter of sculptor Moses Jacob Ezekiel. The newlyweds returned to Chicago, where Williams became chief of surgery at Provident Hospital. Death and Legacy After resigning from his position at Provident Hospital in 1912, Williams was appointed staff surgeon at St. Lukes Hospital in Chicago. Among his many honors, he was named the American College of Surgeons first black fellow. He remained at St. Lukes Hospital until suffering a stroke in 1926. Upon his retirement, Williams spent his remaining days in Idlewild, Michigan, where he died on August 4, 1931. Dr. Daniel Hale Williams would leave a legacy of greatness in the face of discrimination. He demonstrated that African Americans are no less intelligent or valuable than any other Americans. He saved many lives by establishing Provident Hospital and provided proficient medical care, and he also helped train a new generation of African American physicians and nurses. Sources Daniel Hale Willaims : Alumni Exhibit. Walter Dill Scott, University Archives, Northwestern University Library, Northwestern University Archives (NUL), exhibits.library.northwestern.edu/archives/exhibits/alumni/williams.html.Daniel Hale Williams. Biography.com, AE Networks Television, 19 Jan. 2018, www.biography.com/people/daniel-hale-williams-9532269.History - Dr. Daniel Hale Williams. The Provident Foundation, www.providentfoundation.org/index.php/history/history-dr-daniel-hale-williams.Nations Second Open-Heart Surgery Performed In Chicago 119 Years Ago. The Huffington Post, TheHuffingtonPost.com, 10 July 2017, www.huffingtonpost.com/2012/07/09/daniel-hale-williams-perf_n_1659949.html.
Wednesday, November 6, 2019
Informative Essay Sample on the Photographer #8211; Lee Towndrow
Informative Essay Sample on the Photographer #8211; Lee Towndrow Essay on Lee Towndrow the Photographer Lee Towndrow is a renowned commercial and portrait photographer from Canada but currently based in U.S.A. Lee Towndrow began his profession as a photographer and designer with a design firm that he founded. The firm was popularly known for the artwork of creating the album cover for prominent bands from Canada including Sloan, The Inbreds, The Flashing Lights and Michelle McAdorey. Towndrow became a Flame artist in 2000. This happened at TOPIX Computer Graphics, an exposure that he utilized in creating effects for TV commercials and various music videos. He lived in Buenos Aires from 2004 to 2005, the place from which, he did a collaboration with Roberto Jacoby, Raumlabor-Berlin, m7red, Kiwi, Eugenia Herrera, and Cecilia Sainz on conceptual art projects like Proyecto Venus, ArteBA and Darkroom. Every product of Towndrow is appealing and captures my attention. As part of his achievements, one of Lee Towndrowââ¬â¢s photographs was featured on the Applied Arts Photographyââ¬â¢s cover as well as on the Illustration Annual which happened in the year 2000. Some other two photographs of Lee were selected and featured in the 2011 Graphics Top 100 collection of photographs. His series of achievements are a source of motivation to every lover of photography. Lee Towndrow has a website, ââ¬Å"www.leetowndrow.comâ⬠, that has peculiar features. Amongst the coolest features of Leeââ¬â¢s site, is that it portrays the ability of viewing all the hosted photos on a single gigantic ââ¬Å"wall,â⬠as does the Cooliris application for web browsers. From the web, the viewer is at liberty to choosing a picture and viewing it as sideshow of the images featured in a row. Some photos tell a story, for example, the grainy, images of the night vision featuring strange wandering creatures. Other pictures represent cool portraits, captured from interesting angles that are with bright and enthusiastic colors. Some portray just plain crazy. All of these amongst many pictures are awesome. Though these photos are not detailed, the bio tells all we need in appealing and colorful way. The website displays simplicity without relying on various overly gimmicks of appealing to viewers. It merely displays honest, clever, and straightforward abilities of Lees Towndrow. From an I.T point of view, I treasure these attributes of Leesââ¬â¢ website. According to Lees, in his personal project titled anachronisms, he constructed a series of anachronisms like a means of studying fashion image and intimacy. This exposition inspires a lot simply by revealing of how he had watched the relationships around him change. When one is young, he/she is unfamiliar with intimacy and closeness, and yet all this comes to humans very naturally. And as one grows, there is a tendency of him/her distancing from others, as well as choosing sometimes to only cultivate intimacy with one partner. Towndrow got interested in the outcome, when such rules are reversed. The photographsââ¬â¢ staging is a nod to photography of fashion. Outside the art world, photography of fictional narrative has been portrayed as the almost absolute province of editorialsââ¬â¢ fashion. Leesââ¬â¢ intention was to play by those principles (rules), but consider changing the characters. Images were shot with natural light- only reflectors and mirrors were used to light t he scenes. It was termed the self-imposed production rule. Do you need professional help with essay writing online? Our custom essay writing service will write a custom paper for you, on any topic!
Monday, November 4, 2019
Critically evaluate what problems are caused by drugs among youth Essay
Critically evaluate what problems are caused by drugs among youth population in UK - Essay Example There are many problems that affect young users of drugs in United Kingdom. In this essay we will present such problems that are a consequence of drug use among the younger population and some remedies will also be suggested. Problems Caused by Drugs Drug use is extremely detrimental for the society as well as the user of drug. It harms the society by increasing anti social behavior and it is health wise perilous for the user of drugs. The problems caused by drugs multiply when the abuse of drugs is done by younger people. Drug use among youth of United Kingdom is a big problem for the country. The problems caused by drug use among youth are increasing in United Kingdom. Below we will highlight some main problems of drug abuse. The number of young drug addicts has been increasing quite rapidly in United Kingdom. In 2009 a study concluded that there has been a 12 percent increase in drug users aged 13 to24 in UK in the past two years (Reed, J. & Fairbairn, I. 2009). This shows the ext ent of the problem. Development of media and internet is also giving youth access to information on different drugs and this may be a potent reason for the increase in use of drugs among youth in United Kingdom. ... The crimes conducted by drug users were found to be great in United Kingdom. Around 320,000 drug users were found to be involved in serious criminal activity in UK (Steele, J. 2007). The drug addiction rate of United Kingdom is also the highest in Europe. The main contributors to the addiction rate are the younger people of UK. Criminal activities cost law enforcement agencies a lot while the justice and the prison system also have to suffer as a result of the increasing drug use of younger population in the country. Young people also end up joining gangs and many are then involved in the trafficking of same drugs. This is actually increasing the drug problem in United Kingdom and the illicit drug industry is thriving greatly as a result. Young drug addicts are also not able to understand the dangers of their actions. They can easily be inclined to commit violent crimes because of their immature thinking. They are not able to do a cost benefit analysis and can commit crimes just for fun. Drug problems in youth actually lead them to criminals and then these criminal groups manipulate them. This adds to the overall stream of criminal activities in the country. Criminal gangs are fueled by the younger population and drug addiction is one way in which naive youngster fall prey to illicit activities in the society. The reported number of drug offences has decreased in 2010 by 1 percent as compared to the previous year but this decrease only tells us that the policing practice has changed regarding drug offenses (Home Office UK, 2011). This decrease does not mean that drug offenses have decreased rather this show a decrease in reporting of drug offenses. This is another problem of drug use among the youth in United Kingdom. The culture of drugs is
Saturday, November 2, 2019
Phase 1 Discussion Board 3 Essay Example | Topics and Well Written Essays - 1250 words
Phase 1 Discussion Board 3 - Essay Example Some of the management tools that aid the process of governing employee behavior include the code of conduct and ethical principles. Codes of conduct are clearly crafted rules that govern behavior of employees at the work place. The set of guidelines contain the dos and the donââ¬â¢ts of the organization. They further give a clear outline of appropriate disciplinary actions taken against an employee who contravene them. Ethical principles on the other hand refer to accepted behaviors. These are not written and have no mechanism effecting their compliance. Each society and profession has a number of acceptable behaviors and conduct to which every practitioner or member is required to abide by, failing to results to either lack of professionalism or gross misconduct. The ethical codes are in most cases reinstated in the codes of conduct of most professions (Davis, Giordano, & Licht, 2009). However, an individual is required to have a sense of responsive behavior in the conduct of bu siness transactions. Management in business refers to the coordinating, overseeing and supervising the activities in the organization with the aim of achieving the organizationââ¬â¢s objectives. In doing this, the management ensures that all employees have the right mindset and are geared towards the attainment of the same. ... To a achieve this, the management must effectively and adequately understand the concept of management and the theories governing the same. Contingency theory of management postulates that each situation in the organization is unique and requires unique strategies to accomplish. This theory dictates that rather than having a universal approach to every situation, an organization should tailor make strategies for every situation. This way, the unique features of the situation are addressed. This is the most practical approach and is in most cases cost effective. Another theory of management that is equally effective is the systems theory. This theory views an organization as a system with four components that include input, transformational process, outputs, and feedback. Each of these four is integral to the attainment of the organizational objectives and must therefore be effectively coordinated. There are two types of organizational systems, the open, and the close system. A closed system does not interact with the external environment while and open system operates in constant interaction with the environment (Coon & Mitterer, 2011). Two theorists, Abraham Maslow and Douglas McGregor in analyzing the behavioral viewpoint of management hypothesized that human relations movements emphasize social factors at work resulting in group dynamics. It is common to find informal class groupings at a palace of work. These groupings are formed n the basis of mutual interest of the members. Despite being formal and irrelevant to the direct process production, the groups require effective management since they shape employee mindset. In such groups, employee come together especially at tea or lunch breaks and discuss social issues
Subscribe to:
Posts (Atom)